These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15019313)

  • 1. The uniocular drug trial and second-eye response to glaucoma medications.
    Realini T; Fechtner RD; Atreides SP; Gollance S
    Ophthalmology; 2004 Mar; 111(3):421-6. PubMed ID: 15019313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications.
    Realini T; Vickers WR
    Ophthalmology; 2005 Apr; 112(4):599-602. PubMed ID: 15808250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
    Realini TD
    Ophthalmology; 2009 Jul; 116(7):1237-42. PubMed ID: 19576495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma.
    Dinn RB; Zimmerman MB; Shuba LM; Doan AP; Maley MK; Greenlee EC; Alward WL; Kwon YH
    Ophthalmology; 2007 May; 114(5):915-20. PubMed ID: 17467528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocular trial of intraocular pressure-lowering medication: a prospective study.
    King AJ; Uppal S; Rotchford AP; Lakshumanan A; Abedin A; Henry E
    Ophthalmology; 2011 Nov; 118(11):2190-5. PubMed ID: 21724262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects.
    Takahashi M; Higashide T; Sakurai M; Sugiyama K
    J Glaucoma; 2008; 17(3):169-74. PubMed ID: 18414100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time.
    Hedman K; Taube A
    Contemp Clin Trials; 2005 Jun; 26(3):402-15. PubMed ID: 15911474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uniocular drug trial.
    Jones R; Triana MI; Zaslow K; Sponsel WE
    Ophthalmology; 2005 Jun; 112(6):1170; author reply 1170-1. PubMed ID: 15936449
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.
    Doi LM; Melo LA; Prata JA
    Br J Ophthalmol; 2005 May; 89(5):547-9. PubMed ID: 15834081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The one-eye trial and fellow eye response to prostaglandin analogues.
    Dayanir V; Cakmak H; Berkit I
    Clin Exp Ophthalmol; 2008 Mar; 36(2):136-41. PubMed ID: 18352869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study.
    Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P
    Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.